82 related articles for article (PubMed ID: 15522113)
1. The pp67 mRNA assay in treatment and monitoring of cytomegalovirus disease in renal transplant patients in India.
Wattal C; Joshi S; Gupta A; Sharma A; Oberoi JK; Prasad KJ; Rana DS; Bhalla A; Khullar D
Transpl Infect Dis; 2004 Jun; 6(2):90-2. PubMed ID: 15522113
[TBL] [Abstract][Full Text] [Related]
2. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients.
Merlino C; Bergallo M; Gregori G; Sinesi F; Bollero C; Cavallo R
New Microbiol; 2002 Jan; 25(1):1-8. PubMed ID: 11837384
[TBL] [Abstract][Full Text] [Related]
3. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
[TBL] [Abstract][Full Text] [Related]
4. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
[TBL] [Abstract][Full Text] [Related]
6. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients.
Renoult E; Clermont MJ; Phan V; Buteau C; Alfieri C; Tapiero B
Pediatr Transplant; 2008 Jun; 12(4):420-5. PubMed ID: 18466427
[TBL] [Abstract][Full Text] [Related]
7. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
[TBL] [Abstract][Full Text] [Related]
8. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
[TBL] [Abstract][Full Text] [Related]
10. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
[TBL] [Abstract][Full Text] [Related]
12. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
[TBL] [Abstract][Full Text] [Related]
14. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA.
Greijer AE; Adriaanse HM; Dekkers CA; Middeldorp JM
J Clin Virol; 2002 Feb; 24(1-2):57-66. PubMed ID: 11744429
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages.
Keightley MC; Rinaldo C; Bullotta A; Dauber J; St George K
J Clin Virol; 2006 Dec; 37(4):258-64. PubMed ID: 16978918
[TBL] [Abstract][Full Text] [Related]
16. Use of CMV transcripts for monitoring of CMV infections in transplant recipients.
Gerna G; Baldanti F; Middeldorp J; Lilleri D
Int J Antimicrob Agents; 2000 Dec; 16(4):455-60. PubMed ID: 11118857
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
18. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
19. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
[TBL] [Abstract][Full Text] [Related]
20. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G
Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
